[{"Assets_0_Q3_USD":45551816.0,"CommonStockSharesOutstanding_0_Q3_shares":40588004.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-18987454.0,"NetIncomeLoss_1_Q3_USD":-4647930.0,"NetIncomeLoss_3_Q3_USD":-18824371.0,"StockholdersEquity_0_Q3_USD":41714449.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":40588004.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":40588004.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]